Here are four things to know:
1. Mr. Wu is the managing director of NFQ Ventures, a private equity firm. He has founded seven companies over the course of his career.
2. He also serves as a director on the board of Green Shield, a health benefits insurance and financial services company.
3. Antibe focuses on developing medications for pain and inflammation. Its lead drug is ATB-346.
4. The company recent recruited the final patient for its phase 2 clinical trial examining the efficacy of ATB-346 in patients with osteoarthritis.
More articles on GI/endoscopy:
Healthmark adds Endo Bin & Trolley Set; enables controlled delivery & retrievable system for endoscopes
Dr. Maxime Mahe wins 2016 AGA-Athena Troxel Blackburn Award: 4 notes
Pancreatic cysts indicate higher risk of cancer: 4 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.